Primary Secretory Carcinoma of the Thyroid Gland with ETV6::NTRK3 Gene Fusion

Endocr Pathol. 2024 Sep;35(3):274-275. doi: 10.1007/s12022-024-09820-5. Epub 2024 Jul 22.

Authors

Rumeal D Whaley¹, Lori A Erickson²

Affiliations

¹ Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA. [email protected].
² Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA.

PMID: 39037616
DOI: 10.1007/s12022-024-09820-5

No abstract available

Keywords: ETV6; MASC; Mammary analogue secretory carcinoma; Molecular; NTRK3; Salivary gland; Secretory carcinoma; Thyroid gland.

Publication types

Case Reports

MeSH terms

Adult
Carcinoma / genetics
Carcinoma / pathology
ETS Translocation Variant 6 Protein
Female
Humans
Male
Oncogene Proteins, Fusion* / genetics
Proto-Oncogene Proteins c-ets / genetics
Receptor, trkC
Repressor Proteins / genetics
Thyroid Neoplasms* / genetics
Thyroid Neoplasms* / pathology

Substances

Oncogene Proteins, Fusion
ETV6-NTRK3 fusion protein, human
Repressor Proteins
Proto-Oncogene Proteins c-ets
ETS Translocation Variant 6 Protein
Receptor, trkC